Global Medical Rehabilitation Robotics Market 2021-2031

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4.1. Technology Assessment
4.2. Strategic Promotional Strategies
4.3. Recent product Launches
4.4. Regulatory Landscape
4.5. Reimbursement Outlook
4.6. Supply Chain Analysis

5.1. Macro-Economic Factors
5.1.1. Key Facts and Prevalence
5.1.2. Global GDP Growth Outlook
5.1.3. Global Healthcare Expenditure Outlook
5.1.4. Per-Capita Healthcare Expenditure
5.1.5. Medical Robot Market- Parent Analysis
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising Prevalence of Neurological Disorders and Traumatic Brain Injuries
5.2.2. Growing Technological Advancements and Increasing demand for Rehabilitation Robots to support market growth
5.2.3. Aging Population and increase in cases of stroke to drive market growth
5.2.4. Integration into Developmentally Informative Research Designs to Increase Ease of Use in Neurodevelopmental Populations
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity

6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 financial analysis
6.4. COVID19 and Impact Analysis
6.5. 2020 Market Scenario

7.1. Historical Market Value (US$ Mn) Analysis, 2016 - 2020
7.2. Current and Future Market Value (US$ Mn) Projections, 2021 - 2031
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis

8.1. Regional Pricing Analysis By Product Type
8.2. Global Average Pricing Analysis Benchmark

9.1. Historical Market Volume (in Units) Analysis, 2016 - 2020
9.2. Current and Future Market Volume (in Units) Projections, 2021 - 2031
9.2.1. Y-o-Y Growth Trend Analysis

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2016 - 2020
10.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Product Type, 2021 - 2031
10.3.1. Exoskeleton
10.3.2. Therapeutic/ Assistive
10.4. Market Attractiveness Analysis By Product Type

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis by Extremity, 2016 - 2020
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Extremity, 2021 - 2031
11.3.1. Upper extremity
11.3.1.1. Arm
11.3.1.2. Wrist
11.3.1.3. Shoulder
11.3.1.4. Elbow
11.3.2. Lower extremity
11.4. Market Attractiveness Analysis By Extremity

12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis by Therapy Type, 2016 - 2020
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Therapy Type, 2021 - 2031
12.3.1. Limb mobility
12.3.2. Gait
12.3.3. Sensory
12.4. Market Attractiveness Analysis By Therapy Type

13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Analysis by Patient Type, 2016 - 2020
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Patient Type, 2021 - 2031
13.3.1. Adult
13.3.2. Paediatric
13.4. Market Attractiveness Analysis By Patient Type

14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) Analysis by Application, 2016 - 2020
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2021 - 2031
14.3.1. Neurorehabilitation
14.3.2. Physical Rehabilitation
14.3.3. Others
14.4. Market Attractiveness Analysis By Application

15.1. Introduction / Key Findings
15.2. Historical Market Size (US$ Mn) Analysis by End User, 2016 - 2020
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2021 - 2031
15.3.1. Hospitals
15.3.2. Wellness Centers
15.3.3. Rehabilitation centers
15.3.4. Home care
15.4. Market Attractiveness Analysis By End User

16.1. Introduction
16.2. Historical Market Size (US$ Mn) & Volume Analysis by Region, 2016 - 2020
16.3. Current Market Size (US$ Mn) Analysis and Volume Forecast by Region, 2021 - 2031
16.3.1. North America
16.3.2. Latin America
16.3.3. Europe
16.3.4. South Asia
16.3.5. East Asia
16.3.6. Oceania
16.3.7. Middle East and Africa (MEA)
16.4. Market Attractiveness Analysis by Region

17.1. Introduction
17.2. Historical Market Size (US$ Mn) & Volume Trend Analysis by Market Taxonomy, 2016 - 2020
17.3. Market Size (US$ Mn) & Volume Forecast by Market Taxonomy, 2021 - 2031
17.3.1. By Country
17.3.1.1. U.S.
17.3.1.2. Canada
17.3.2. By Product Type
17.3.3. By Extremity
17.3.4. By Therapy Type
17.3.5. By Patient Type
17.3.6. By Application
17.3.7. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis

18.1. Introduction
18.2. Historical Market Size (US$ Mn) & Volume Trend Analysis by Market Taxonomy, 2016 - 2020
18.3. Market Size (US$ Mn) & Volume Forecast by Market Taxonomy, 2021 - 2031
18.3.1. By Country
18.3.1.1. Brazil
18.3.1.2. Mexico
18.3.1.3. Argentina
18.3.1.4. Rest of Latin America
18.3.2. By Product Type
18.3.3. By Extremity
18.3.4. By Therapy Type
18.3.5. By Patient Type
18.3.6. By Application
18.3.7. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis

19.1. Introduction
19.2. Historical Market Size (US$ Mn) & Volume Trend Analysis by Market Taxonomy, 2016 - 2020
19.3. Market Size (US$ Mn) & Volume Forecast by Market Taxonomy, 2021 - 2031
19.3.1. By Country
19.3.1.1. U.K.
19.3.1.2. Germany
19.3.1.3. Italy
19.3.1.4. France
19.3.1.5. Spain
19.3.1.6. BENELUX
19.3.1.7. Russia
19.3.1.8. Rest of Europe
19.3.2. By Product Type
19.3.3. By Extremity
19.3.4. By Therapy Type
19.3.5. By Patient Type
19.3.6. By Application
19.3.7. By End User
19.4. Market Attractiveness Analysis
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis

20.1. Introduction
20.2. Historical Market Size (US$ Mn) & Volume Trend Analysis by Market Taxonomy, 2016 - 2020
20.3. Market Size (US$ Mn) & Volume Forecast by Market Taxonomy, 2021 - 2031
20.3.1. By Country
20.3.1.1. India
20.3.1.2. Thailand
20.3.1.3. Indonesia
20.3.1.4. Malaysia
20.3.1.5. Rest of South Asia
20.3.2. By Product Type
20.3.3. By Extremity
20.3.4. By Therapy Type
20.3.5. By Patient Type
20.3.6. By Application
20.3.7. By End User
20.4. Market Attractiveness Analysis
20.5. Key Market Participants - Intensity Mapping
20.6. Drivers and Restraints - Impact Analysis

21.1. Introduction
21.2. Historical Market Size (US$ Mn) & Volume Trend Analysis by Market Taxonomy, 2016 - 2020
21.3. Market Size (US$ Mn) & Volume Forecast by Market Taxonomy, 2021 - 2031
21.3.1. By Country
21.3.1.1. China
21.3.1.2. Japan
21.3.1.3. South Korea
21.3.2. By Product Type
21.3.3. By Extremity
21.3.4. By Therapy Type
21.3.5. By Patient Type
21.3.6. By Application
21.3.7. By End User
21.4. Market Attractiveness Analysis
21.5. Key Market Participants - Intensity Mapping
21.6. Drivers and Restraints - Impact Analysis

22.1. Introduction
22.2. Historical Market Size (US$ Mn) & Volume Trend Analysis by Market Taxonomy, 2016 - 2020
22.3. Market Size (US$ Mn) & Volume Forecast by Market Taxonomy, 2021 - 2031
22.3.1. By Country
22.3.1.1. Australia
22.3.1.2. New Zealand
22.3.2. By Product Type
22.3.3. By Extremity
22.3.4. By Therapy Type
22.3.5. By Patient Type
22.3.6. By Application
22.3.7. By End User
22.4. Market Attractiveness Analysis
22.5. Key Market Participants - Intensity Mapping
22.6. Drivers and Restraints - Impact Analysis

23.1. Introduction
23.2. Historical Market Size (US$ Mn) & Volume Trend Analysis by Market Taxonomy, 2016 - 2020
23.3. Market Size (US$ Mn) & Volume Forecast by Market Taxonomy, 2021 - 2031
23.3.1. By Country
23.3.1.1. GCC Countries
23.3.1.2. South Africa
23.3.1.3. Turkey
23.3.1.4. North Africa
23.3.1.5. Rest of Middle East and Africa
23.3.2. By Product Type
23.3.3. By Extremity
23.3.4. By Therapy Type
23.3.5. By Patient Type
23.3.6. By Application
23.3.7. By End User
23.4. Market Attractiveness Analysis
23.5. Key Market Participants - Intensity Mapping
23.6. Drivers and Restraints - Impact Analysis

24.1. Introduction
24.1.1. Market Value Proportion Analysis, By Key Countries
24.1.2. Global Vs. Country Growth Comparison
24.2. U.S.Medical Rehabilitation Robotics Market Analysis
24.2.1. By Product Type
24.2.2. By Extremity
24.2.3. By Therapy Type
24.2.4. By Patient Type
24.2.5. By Application
24.2.6. By End User
24.3. Canada Medical Rehabilitation Robotics Market Analysis
24.3.1. By Product Type
24.3.2. By Extremity
24.3.3. By Therapy Type
24.3.4. By Patient Type
24.3.5. By Application
24.3.6. By End User
24.4. Brazil Medical Rehabilitation Robotics Market Analysis
24.4.1. By Product Type
24.4.2. By Extremity
24.4.3. By Therapy Type
24.4.4. By Patient Type
24.4.5. By Application
24.4.6. By End User
24.5. Mexico Medical Rehabilitation Robotics Market Analysis
24.5.1. By Product Type
24.5.2. By Extremity
24.5.3. By Therapy Type
24.5.4. By Patient Type
24.5.5. By Application
24.5.6. By End User
24.6. Argentina Medical Rehabilitation Robotics Market Analysis
24.6.1. By Product Type
24.6.2. By Extremity
24.6.3. By Therapy Type
24.6.4. By Patient Type
24.6.5. By Application
24.6.6. By End User
24.7. U.K.Medical Rehabilitation Robotics Market Analysis
24.7.1. By Product Type
24.7.2. By Extremity
24.7.3. By Therapy Type
24.7.4. By Patient Type
24.7.5. By Application
24.7.6. By End User
24.8. Germany Medical Rehabilitation Robotics Market Analysis
24.8.1. By Product Type
24.8.2. By Extremity
24.8.3. By Therapy Type
24.8.4. By Patient Type
24.8.5. By Application
24.8.6. By End User
24.9. France Medical Rehabilitation Robotics Market Analysis
24.9.1. By Product Type
24.9.2. By Extremity
24.9.3. By Therapy Type
24.9.4. By Patient Type
24.9.5. By Application
24.9.6. By End User
24.10. Italy Medical Rehabilitation Robotics Market Analysis
24.10.1. By Product Type
24.10.2. By Extremity
24.10.3. By Therapy Type
24.10.4. By Patient Type
24.10.5. By Application
24.10.6. By End User
24.11. Spain Medical Rehabilitation Robotics Market Analysis
24.11.1. By Product Type
24.11.2. By Extremity
24.11.3. By Therapy Type
24.11.4. By Patient Type
24.11.5. By Application
24.11.6. By End User
24.12. Russia Medical Rehabilitation Robotics Market Analysis
24.12.1. By Product Type
24.12.2. By Extremity
24.12.3. By Therapy Type
24.12.4. By Patient Type
24.12.5. By Application
24.12.6. By End User
24.13. BENELUX Medical Rehabilitation Robotics Market Analysis
24.13.1. By Product Type
24.13.2. By Extremity
24.13.3. By Therapy Type
24.13.4. By Patient Type
24.13.5. By Application
24.13.6. By End User
24.14. China Medical Rehabilitation Robotics Market Analysis
24.14.1. By Product Type
24.14.2. By Extremity
24.14.3. By Therapy Type
24.14.4. By Patient Type
24.14.5. By Application
24.14.6. By End User
24.15. Japan Medical Rehabilitation Robotics Market Analysis
24.15.1. By Product Type
24.15.2. By Extremity
24.15.3. By Therapy Type
24.15.4. By Patient Type
24.15.5. By Application
24.15.6. By End User
24.16. S. Korea Medical Rehabilitation Robotics Market Analysis
24.16.1. By Product Type
24.16.2. By Extremity
24.16.3. By Therapy Type
24.16.4. By Patient Type
24.16.5. By Application
24.16.6. By End User
24.17. India Medical Rehabilitation Robotics Market Analysis
24.17.1. By Product Type
24.17.2. By Extremity
24.17.3. By Therapy Type
24.17.4. By Patient Type
24.17.5. By Application
24.17.6. By End User
24.18. Thailand Medical Rehabilitation Robotics Market Analysis
24.18.1. By Product Type
24.18.2. By Extremity
24.18.3. By Therapy Type
24.18.4. By Patient Type
24.18.5. By Application
24.18.6. By End User
24.19. Indonesia Medical Rehabilitation Robotics Market Analysis
24.19.1. By Product Type
24.19.2. By Extremity
24.19.3. By Therapy Type
24.19.4. By Patient Type
24.19.5. By Application
24.19.6. By End User
24.20. Malaysia Medical Rehabilitation Robotics Market Analysis
24.20.1. By Product Type
24.20.2. By Extremity
24.20.3. By Therapy Type
24.20.4. By Patient Type
24.20.5. By Application
24.20.6. By End User
24.21. Australia Medical Rehabilitation Robotics Market Analysis
24.21.1. By Product Type
24.21.2. By Extremity
24.21.3. By Therapy Type
24.21.4. By Patient Type
24.21.5. By Application
24.21.6. By End User
24.22. New Zealand Medical Rehabilitation Robotics Market Analysis
24.22.1. By Product Type
24.22.2. By Extremity
24.22.3. By Therapy Type
24.22.4. By Patient Type
24.22.5. By Application
24.22.6. By End User
24.23. GCC Countries Medical Rehabilitation Robotics Market Analysis
24.23.1. By Product Type
24.23.2. By Extremity
24.23.3. By Therapy Type
24.23.4. By Patient Type
24.23.5. By Application
24.23.6. By End User
24.24. South Africa Medical Rehabilitation Robotics Market Analysis
24.24.1. By Product Type
24.24.2. By Extremity
24.24.3. By Therapy Type
24.24.4. By Patient Type
24.24.5. By Application
24.24.6. By End User
24.25. Turkey Medical Rehabilitation Robotics Market Analysis
24.25.1. By Product Type
24.25.2. By Extremity
24.25.3. By Therapy Type
24.25.4. By Patient Type
24.25.5. By Application
24.25.6. By End User
24.26. North Africa Medical Rehabilitation Robotics Market Analysis
24.26.1. By Product Type
24.26.2. By Extremity
24.26.3. By Therapy Type
24.26.4. By Patient Type
24.26.5. By Application
24.26.6. By End User

25.1. Market Analysis by Tier of Companies
25.2. Market Share Analysis
25.3. Market Presence Analysis
25.3.1. Regional footprint of players
25.3.2. Product footprint of players
25.3.3. Channel footprint of players

26.1. Competition Dashboard
26.2. Competition Benchmarking
26.3. Competition Deep Dive
26.3.1. Ekso Bionics Holdings Inc.
26.3.1.1. Overview & Key Financials
26.3.1.2. SWOT Analysis
26.3.1.3. Sales Footprint
26.3.1.4. Analyst commentary
26.3.1.5. Strategy Overview
26.3.1.5.1. Marketing Strategy
26.3.1.5.2. Product Type Strategy
26.3.1.5.3. Channel Strategy
26.3.2. AlterG, Inc.
26.3.2.1. Overview & Key Financials
26.3.2.2. SWOT Analysis
26.3.2.3. Sales Footprint
26.3.2.4. Analyst commentary
26.3.2.5. Strategy Overview
26.3.2.5.1. Marketing Strategy
26.3.2.5.2. Product Type Strategy
26.3.2.5.3. Channel Strategy
26.3.3. Bionik Laboratories Corp.
26.3.3.1. Overview & Key Financials
26.3.3.2. SWOT Analysis
26.3.3.3. Sales Footprint
26.3.3.4. Analyst commentary
26.3.3.5. Strategy Overview
26.3.3.5.1. Marketing Strategy
26.3.3.5.2. Product Type Strategy
26.3.3.5.3. Channel Strategy
26.3.4. Cyberdyne Inc.
26.3.4.1. Overview & Key Financials
26.3.4.2. SWOT Analysis
26.3.4.3. Sales Footprint
26.3.4.4. Analyst commentary
26.3.4.5. Strategy Overview
26.3.4.5.1. Marketing Strategy
26.3.4.5.2. Product Type Strategy
26.3.4.5.3. Channel Strategy
26.3.5. ReWalk Robotics
26.3.5.1. Overview & Key Financials
26.3.5.2. SWOT Analysis
26.3.5.3. Sales Footprint
26.3.5.4. Analyst commentary
26.3.5.5. Strategy Overview
26.3.5.5.1. Marketing Strategy
26.3.5.5.2. Product Type Strategy
26.3.5.5.3. Channel Strategy
26.3.6. Instead Technologies Ltd.
26.3.6.1. Overview & Key Financials
26.3.6.2. SWOT Analysis
26.3.6.3. Sales Footprint
26.3.6.4. Analyst commentary
26.3.6.5. Strategy Overview
26.3.6.5.1. Marketing Strategy
26.3.6.5.2. Product Type Strategy
26.3.6.5.3. Channel Strategy
26.3.7. Hocoma AG
26.3.7.1. Overview & Key Financials
26.3.7.2. SWOT Analysis
26.3.7.3. Sales Footprint
26.3.7.4. Analyst commentary
26.3.7.5. Strategy Overview
26.3.7.5.1. Marketing Strategy
26.3.7.5.2. Product Type Strategy
26.3.7.5.3. Channel Strategy
26.3.8. Fourier Intelligence
26.3.8.1. Overview & Key Financials
26.3.8.2. SWOT Analysis
26.3.8.3. Sales Footprint
26.3.8.4. Analyst commentary
26.3.8.5. Strategy Overview
26.3.8.5.1. Marketing Strategy
26.3.8.5.2. Product Type Strategy
26.3.8.5.3. Channel Strategy
26.3.9. Tyromotion
26.3.9.1. Overview & Key Financials
26.3.9.2. SWOT Analysis
26.3.9.3. Sales Footprint
26.3.9.4. Analyst commentary
26.3.9.5. Strategy Overview
26.3.9.5.1. Marketing Strategy
26.3.9.5.2. Product Type Strategy
26.3.9.5.3. Channel Strategy
26.3.10. Toyota Motor Corporation
26.3.10.1. Overview & Key Financials
26.3.10.2. SWOT Analysis
26.3.10.3. Sales Footprint
26.3.10.4. Analyst commentary
26.3.10.5. Strategy Overview
26.3.10.5.1. Marketing Strategy
26.3.10.5.2. Product Type Strategy
26.3.10.5.3. Channel Strategy
26.3.11. BeatBots LLC
26.3.11.1. Overview & Key Financials
26.3.11.2. SWOT Analysis
26.3.11.3. Sales Footprint
26.3.11.4. Analyst commentary
26.3.11.5. Strategy Overview
26.3.11.5.1. Marketing Strategy
26.3.11.5.2. Product Type Strategy
26.3.11.5.3. Channel Strategy
26.3.12. LEADERS REHAB ROBOT Co. Ltd.
26.3.12.1. Overview & Key Financials
26.3.12.2. SWOT Analysis
26.3.12.3. Sales Footprint
26.3.12.4. Analyst commentary
26.3.12.5. Strategy Overview
26.3.12.5.1. Marketing Strategy
26.3.12.5.2. Product Type Strategy
26.3.12.5.3. Channel Strategy